Fri.Nov 17, 2023

article thumbnail

AstraZeneca’s first-in-class FDA approval for Truqap marred by surprise restriction

Fierce Pharma

After the landmark success of Enhertu in HER2-low breast cancer, AstraZeneca has blazed another trail in the world’s most common cancer type. | After the landmark success of Enhertu in HER2-low breast cancer, AstraZeneca has blazed another trail in the world’s most common cancer type. But an unexpected restriction has cast a dark cloud over the first-in-class approval.

FDA 291
article thumbnail

From Inequality to Empowerment: The Role of Automation Technologies in Healthcare

MedCity News

Automation can be a powerful tool to bring together all the pieces needed to provide optimal care that can be scattered across various systems and apps. Whether it’s to exchange patient data quickly and easily, identify communities in need of programs to address food inequity, or reduce no-shows by sending automatic reminders, using the right technology is an essential tool for achieving better patient care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca plans to exit 'beating heart' of Indian operations in Bangalore

Fierce Pharma

Amid a corporate review of AstraZeneca’s global manufacturing and supply network, the company’s Indian subsidiary is planning to close up shop at the “beating heart” of its India operations in Bang | AstraZeneca Pharma India will exit its production plant in Bangalore, India, “in due course,” the company said in a filing. AZ plans to find a buyer who can also serve as a contract manufacturer for the drugs produced there.

article thumbnail

Why Employers and Payers Should Offer Companionship Services, Per Papa’s CEO

MedCity News

A recent report from Papa, a companion care company, found that 22% of Medicare Advantage members are severely lonely. The findings give some insights into why employers and payers should offer companion support, according to Andrew Parker, founder and CEO of Papa.

106
106
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

FDA signs off on new uses for Astellas and Pfizer's Xtandi, Merck's Keytruda

Fierce Pharma

The FDA has signed off on label expansions for two of the world’s most important cancer medicines—Merck’s Keytruda and Pfizer and Astellas’ Xtandi. | The FDA has signed off on label expansions for two of the world’s most important cancer medicines—Merck’s Keytruda and Pfizer and Astellas’ Xtandi. Keytruda’s expansion is in stomach cancer. Xtandi’s new indication expands its already deep portfolio in the treatment of prostate cancer.

FDA 283
article thumbnail

Why Abbott Believes Its New Pacemaker Will Help It Capture More Market Share

MedCity News

Abbott’s new leadless pacemaker system has become commercially available and has begun being implanted in people at hospitals across the nation. Most people who need a pacemaker require pacing in two chambers of the heart, and the dual-chamber technology in Abbott’s new system allows these patients to have a leadless pacemaker.

Marketing 105

More Trending

article thumbnail

EC approves lebrikizumab for atopic dermatitis

European Pharmaceutical Review

The European Commission has approved Ebglyss (lebrikizumab) for atopic dermatitis patients 12 years and older with a body weight of at least 40kg, who are candidates for systemic therapy. Almirall has licensed the rights to develop and commercialise lebrikizumab for the treatment of dermatology indications in Europe. The company said it will launch lebrikizumab in Germany, with further European rollout planned throughout 2024.

Safety 98
article thumbnail

CDC rushes extra doses of Sanofi, AZ's Beyfortus to ease supply shortfall

Fierce Pharma

In response to a supply squeeze for Sanofi and AstraZeneca’s respiratory syncytial virus (RSV) antibody Beyfortus, the U.S. | Sanofi and AstraZeneca's highly anticipated infant RSV immunization ran into supply issues just a few months into its launch. In response, government officials are speeding more doses into distribution.

article thumbnail

Looking Ahead to Regulatory Trends in Healthcare IT

MedCity News

The healthcare IT industry is in a state of constant evolution, with regulatory trends shaping the path forward. Continuous updates in certification regulations, the integration of emerging technologies, and data privacy concerns are just some of the challenges facing healthcare IT stakeholders.

article thumbnail

Trial for novel CGRP migraine medicine gleans positive results

European Pharmaceutical Review

Results from AbbVie’s Phase III study, PRODROME , published in The Lancet showed that UBRELVY ® (ubrogepant) 100mg for acute treatment of migraine significantly reduced the likelihood of development of moderate or severe headache compared to placebo within 24 hours post-dose. This was demonstrated when the calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) was administered during the prodrome phase (ie, one to sixurs before the predicted onset of headache pain) of a migraine a

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Micron Biomedical receives funds to produce needle-free vaccines

Pharmaceutical Technology

Micron Biomedical has received $23.6m in funding from the Bill & Melinda Gates Foundation for the bulk manufacturing of needle-free vaccines.

article thumbnail

??A startling drop in U.S. life expectancy — and how pharma could help turn the tide

PharmaVoice

The recently observed dip was particularly acute for men, who now live an average of 5.8 fewer years than women.

Pharma 116
article thumbnail

AstraZeneca Cancer Drug Is First in Class, But FDA Nod Is Narrower Than Expected

MedCity News

The FDA approved AstraZeneca’s Truqap as a new treatment for advanced cases of breast cancer. The drug is the first in a new class of therapies addressing AKT genetic alterations.

FDA 97
article thumbnail

NHS trials artificial intelligence system to prevent avoidable admissions

PharmaTimes

The AI system will identify those most at risk and reduce pressure on the NHS - News - PharmaTimes

116
116
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

The Power of Centralized Distribution in the Face of DSCSA Compliance

Pharmaceutical Commerce

With new mandates right around the corner, there is an unwavering demand for pharma operations to perform at peak efficieny.

article thumbnail

Addressing Widespread Financial Insecurity in the Healthcare Industry

MedCity News

It’s not just our lowest-paid healthcare professionals who suffer from financial insecurity. From the hardworking custodian to the extremely specialized surgeon, all healthcare professionals should be offered the resources and means to keep up with inflation and financial concerns.

article thumbnail

Daiichi Sankyo signs agreement with Japan to supply Covid-19 vaccine

Pharmaceutical Technology

Daiichi Sankyo has signed an agreement with Japan's MHLW to deliver 1.4 million doses of its omicron-adapted mRNA vaccine for Covid-19.

94
article thumbnail

Q&A With Jade Shields, Vice President of Corporate Affairs at Ferring Pharmaceuticals

PharmExec

Shields discusses Ferring’s recent $5 million endowment to the American Society of Reproductive Medicine.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Is it Time for a New Healthcare Brand – Or a Rebrand?

Healthcare Success

Have your products, services, or target audience evolved to the point where they no longer align with your brand? Has your health brand become lost in a sea of sameness? Do your marketing assets feel stale and out of touch with your audience? Did your business neglect to establish proper healthcare branding from the beginning? Whether your current branding isn’t servicing your business anymore or your brand has evolved beyond your existing branding—it’s time for a rebrand.

article thumbnail

Analyzing Risks of Online Marketing for Teeth Whitening Products, Post-COVID

PharmExec

Heliyon study evaluates online information, labeling accuracy, and quantitative analysis of high peroxide content gels.

article thumbnail

New NIHR Research Delivery Network in England announced by DHSC

PharmaTimes

The University of Leeds and NHS organisations will host the network in 2024 - News - PharmaTimes

article thumbnail

StartUPDATES: New developments from healthcare startups

MedCity News

Check out news from Harmony Health Foundation, Gratia Health, Pathway, Fortuna Health, and more.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Hachette Restructures

Copyright Clearance Center

The post Hachette Restructures appeared first on Copyright Clearance Center.

98
article thumbnail

Digital health company BehaVR hits the merger trail again

pharmaphorum

Digital health company BehaVR hits the merger trail again Phil.

108
108
article thumbnail

5 Best Roofing Sales Training Resources

Spotio

Looking to sell more roofs for your roofing business? Proven roofing sales training will help you (or your reps) connect with more customers and close more deals. The question is, which sales training for roofing companies is best? We aim to answer that for you in this article. Keep reading to learn about six specific programs you can use to take your roofing venture to the next level.

article thumbnail

FDA’s Janet Woodcock will step down early next year

pharmaphorum

FDA’s Janet Woodcock will step down early next year Phil.

106
106
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

How to influence care decisions at the point of care

Clarify Health

In this video, Emily Roesing , Senior Director of Product at Clarify Health, discusses how to influence specialist referral and facility selection at the point of care. Transcript I have spent many years focused on finding solutions that will help both payers and providers tackle this question: How can we get patients to visit the best possible specialists and receive care at the right facilities?

article thumbnail

AZ first to AKT finish line, but FDA clears narrow label

pharmaphorum

AZ first to AKT finish line, but FDA clears narrow label Phil.

FDA 97
article thumbnail

How To Make The Best First Impression With Your New Medical Distributor

Cesare Ferrari

Consider this: You worked hard to find and select a new commercial partner in an uncovered market. You and your new distributor invested time and resources to establish what both expect to be a long-term, profitable and fruitful commercial relationship. All the prerequisites are fulfilled, the distribution agreement is signed, and the regulatory departments are working together in harmony to register the products.

Medical 52
article thumbnail

ABPI says UK clinical trials sector ‘improving’

pharmaphorum

ABPI says UK clinical trials sector ‘improving’ Phil.

98
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A